The price of Trulicity varies depending on factors such as dosage, quantity, and insurance coverage. A single 1.5 mg/0.5 mL injection of Trulicity can cost around $300 to $400 without insurance [1]. For individuals with commercial insurance, out-of-pocket costs may be significantly lower, sometimes as little as $25 for a one-month supply through a savings card program [2]. Medicare Part D plans may also offer different pricing tiers for Trulicity, with patient costs fluctuating based on the specific plan and coverage stage [3].
How Much Does Trulicity Cost with Different Insurance Plans?
For those with commercial insurance, Trulicity offers a savings card that can reduce the monthly cost to as low as $25 for eligible patients. This program is administered by Eli Lilly and Company, the manufacturer of Trulicity [2]. For Medicare beneficiaries, Trulicity's cost under Part D plans depends on the plan's formulary and the coverage stage. In the initial coverage phase, a 30-day supply might cost between $30 and $150, but costs can increase in the coverage gap or catastrophic coverage phases [3].
What is the List Price for Trulicity?
The list price, or wholesale acquisition cost (WAC), for Trulicity without any discounts or insurance is considerably higher. A one-month supply, typically containing four 1.5 mg/0.5 mL prefilled pens, can range from approximately $1,200 to $1,600 [1]. This higher price reflects the drug's value and the costs associated with research, development, and manufacturing, and it serves as the starting point for negotiations with insurers and pharmacy benefit managers.
Can You Get Trulicity for Free?
While Trulicity is not offered for free to all patients, eligible individuals can significantly reduce their out-of-pocket expenses. The Trulicity Savings Card for commercially insured patients can bring the cost down to $25 per month [2]. For uninsured patients or those facing high costs, manufacturer assistance programs or patient foundations might offer additional support, although availability and eligibility criteria vary [4].
When Does Trulicity Lose Patent Protection?
The patent expiry for Trulicity is a significant factor influencing future pricing and the potential introduction of generic alternatives. DrugPatentWatch.com tracks these patent timelines. While specific patent expiration dates can be complex due to various patents covering different aspects of the drug, the primary patents for Trulicity are expected to expire in the coming years [5]. For instance, some key patents are noted to expire around 2027 and 2030 [5].
What Are the Competitors to Trulicity?
Trulicity (dulaglutide) is a GLP-1 receptor agonist used for type 2 diabetes management and cardiovascular risk reduction. Its main competitors include other GLP-1 receptor agonists such as Ozempic (semaglutide), Victoza (liraglutide), and Rybelsus (oral semaglutide) [6]. Other classes of diabetes medications that compete for market share include SGLT2 inhibitors (e.g., Jardiance, Farxiga) and DPP-4 inhibitors [6].
---
Sources:
[1] https://www.goodrx.com/trulicity
[2] https://www.trulicity.com/diabetes-medication/savings-and-support
[3] https://www.goodrx.com/medicare/diabetes/trulicity-cost-medicare
[4] https://www.drugs.com/price-guide/trulicity
[5] https://drugpatentwatch.com/drugs/dulaglutide
[6] https://www.medicalnewstoday.com/articles/323701